Leone Asset Management Acquires ALM Research and Development

BELLEAIR BLUFFS, FL / ACCESSWIRE / January 10, 2017 / Today, Leone Asset Management (OTC PINK: LEON) announces that they have acquired ALM Research & Development, Inc., an innovative company specializing in the formulation of innovative nutraceutical and cosmeceutical products.

James Price, CEO of Leone Asset Management, stated, "This is simply an amazing acquisition for Leone Asset. Steve Kushner and ALM R&D have created a game changing technology that greatly enhances the absorption and efficacy of virtually thousands of compounds that are used in nutraceutical and cosmeceutical products. Clinical research was performed at a major independent research facility in the Northeast, where the delivery technology was studied, using a proprietary 3-D skin tissue model, for permeation of and retention of transdermal compounds within the human skin tissue. The results of the studies were extremely encouraging. We are currently using the technology in our subsidiary Go Epic Health's flagship product, Cholesterade®, and the increase in efficacy and overall results have been outstanding. We intend to commit a lot of time and effort in creating new products for our Go Epic Health offering, as well as improving other products existing in the marketplace today under exclusive licensing agreements."

About Leone Asset Management

Leone Asset Management, Inc., is a multi-national, multi-industry conglomerate with subsidiary companies that operate in Health and Wellness in the U.S., Technology Development in India, and Infrastructure development, agriculture management, and mineral exploration and export in Africa. For additional information, visit: www.leoneasset.com.

About ALM Research and Development

ALM Research & Development is a company specializing in the formulation of innovative nutriceutical and cosmeceutical products for both the consumer and professional marketplace and has had several products marketed through major national chains. A major focus of ALM for the past 6 years has been in creating a more efficient method to deliver compounds to the body. As a result, ALM has created a novel platform delivery technology, which is fully patent-pending. It has been clinically demonstrated to increase permeation and duration of activity of compounds through transdermal delivery, as well as enhance active compound uptake and bioavailability when applied orally. The technology not only holds multiple compounds and transports them into the body with unprecedented efficiency, but also has a major positive impact on the surrounding physiology that is the target of delivery for the active ingredients. This technology is in use with a number of topical products in the medical/aesthetic field.

For further information, please visit www.leoneasset.com.

About Go Epic Health

Go Epic Health, a Leone Asset Management subsidiary, is a nutritional product holding company which owns the intellectual property and worldwide manufacturing and distribution rights to Cholesterade®, a natural cholesterol reducing product created by the late Dr. Robert Cade, creator of Gatorade®. Go Epic's wholly owned subsidiary, American Retail Alliance, markets and distributes Cholesterade®, as well as other new and innovative consumer goods through the nation's largest retail pharmacy chain stores, drug and health food stores, multi-level organizations, and product specific catalogs. Wholly owned subsidiary Eagle Labs is a product and contract manufacturing company specializing in manufacturing food, cosmetics, dietary supplements, liquid bottling, and product formulation. For further information, please visit www.goepichealth.com and www.gocholesterade.com.

Forward-Looking Statements Disclosure:

This press release may contain "forward-looking statements" within the meaning of the federal securities laws. In this context, forward-looking statements may address the Company's expected future business and financial performance, and often contain words such as "anticipates," "beliefs," "estimates," "expects," "intends," " plans," "seeks," "will," and other terms with similar meaning. These forward-looking statements by their nature address matter that are, to different degrees, uncertain. Although the Company believes that the assumptions upon which its forward-looking statements based are reasonable, it can provide no assurances that these assumptions will prove to be correct. All forward-looking statements in this press release are expressly qualified by such cautionary statements, risk, and uncertainties, and by reference to the underlying assumptions.

James Price
CEO
Leone Asset Management
(727) 581-1500
jprice@leoneasset.com

SOURCE: Leone Asset Management